As a globally active, independent health care company and one of the leading manufacturers of high-quality and low-cost generics as well as well-known branded products (OTC), our success story stretches back nearly 120 years.
With regard to costs and risks, we deliberately do not conduct any own research on, or marketing of new active pharmaceutical ingredients, but rather focus on the development and marketing of products with active ingredients – generally active pharmaceutical ingredients – which are free from commercial property rights, particularly patents.
Important strategic success factors of the STADA Group
Strategic success factors of the STADA Group
Strong product portfolio
STADA offers an extensive product portfolio for a wide range of therapeutic purposes, such as for pain, women's health, cardiovascular conditions and diabetes. In addition to low-cost, high-quality generics, the product spectrum also includes well-known branded products such as Grippostad® and Ladival®. With a strong product development and a well-filled product pipeline, STADA ensures a continuous flow of product launches and therefore also the continuous expansion of the existing product portfolio – particularly in the Generics segment. With in-licensing from highly-specialized partners, the Group also increasingly expands the promising biosimilars area.
International sales structure
The international sales structure with the four STADA market regions is designed to market the products from the Group portfolio in a way which is adapted to the different regulatory and competitive framework conditions in the individual markets of the respective market regions.
Active acquisition policy
The active acquisition policy aims to expand the Group’s business activities. In this context, STADA focuses on regional expansion, particularly in high-growth emerging markets. In addition, the Group focuses on the expansion and internationalization of the core segments, in particular Branded Products, as they are generally characterized by less regulatory interventions and more attractive margins than the generics area.
Functionally organized Group
In order to achieve future growth, an important role is inherent in the organization by market region with short decision-making structures while at the same time maintaining a strong local market presence. This predominately applies to sales activities, because the ability to react to changes in the short-term is very important, both for exploiting opportunities and reducing risks.
Continuous cost optimization with efficient cost management
In consideration of earnings, continuous cost optimization and efficient cost management play an important role.
Another important opportunity for STADA can be found in the employees who will continue in future to have a significant share in the ongoing success of the Group with their extensive expertise, their great experience and their strong commitment.